我的账户
亲爱的游客

欢迎您的光临

已有账号,请

如尚未注册?

第三方账号快捷登陆

试管婴儿

美国(HRC-Fertility)医院ENCINO (恩西诺):Robert Boostanfar(大卫·托格曼医生)

[复制链接]
meihualu 发表于 2016-1-10 17:25:09 | 显示全部楼层 |阅读模式 打印 上一主题 下一主题
  好国HRC死殖医疗中间:Robert Boostanfar(年夜卫·托格曼大夫)
好国(HRC-Fertility)病院ENCINO (恩西诺):Robert Boostanfar(年夜卫·托格曼大夫)

【年夜卫大夫中文助理微旌旗灯号:1530863253   】

  局认证

  死殖内排泄取没有孕症妇产科

  教术录用

  北减州年夜教医教系妇产科临床传授

  任职阅历

  圣·约翰·安康中间

  好国HRC-Fertility死殖医疗中间

  得到奖项

  惠氏Ayest承平洋海岸的死殖医教奖,1999年4月

  雪兰诺承平洋海岸死殖医教会讲授奖2000年4月

  北减州的妇产科协会颁布奥索-麦克僧我海报奖,2011年2月

  雪兰诺仄洋海岸死殖医教研讨员奖,2001年4月

  承平洋沿岸死殖医教会优良做者奖2001年4月

  专业构造

  好国妇产科医师教会会员

  好国死殖内排泄及没有孕没有育死殖医教会会员

  承平洋海岸死殖医教会的妇科大夫

  范畴狄仔颈巴出书

  进步胚胎着床促排卵药物评价

  阳讲激素办理

  帮助死殖手艺战卵母细胞捐赠育龄妇女的卵子捐赠




【英文简介】


  CURRICULUM VITAE

  A. Personal Information:

  Name David E. Tourgeman, M.D.

  Academic Address Department of Obstetrics and Gynecology Women’s and Children’s Hospital 1240 North Mission Road, Room 8K9 Los Angeles, California 90033 Telephone

  Private Practice Address 11500 W. Olympic Boulevard, Suite 504 Los Angeles, California 90064

  Date of Birth April 19, 1965

  Place of Birth Los Angeles, California

  Citizenship United States of America

  Marital Status Married

  Children One

  B. Education:

  High School Providence High School Burbank, California High School Diploma, June, 1982 Dean’s Honor for Academic Excellence Graduated four-year program in three years

  College University of California, Santa Barbara Santa Barbara, California Bachelors of Science Physiologic Psychology, March, 1987 Dean’s Honor List for Academic Excellence

  2

  B. Education: (Cont’d)

  Medical School University of Southern California School of Medicine Los Angeles, California Doctor of Medicine, May, 1994 Dean’s Scholar Junior/Senior Continuum

  Postgraduate Training:

  Internship Department of Obstetrics and Gynecology Women’s and Children’s Hospital LAC+USC Medical Center 1240 North Mission Road Los Angeles, CA 90033 1994 -1995

  Residency Department of Obstetrics and Gynecology Women’s and Children’s Hospital LAC+USC Medical Center 1240 North Mission Road Los Angeles, CA 90033 1995 -1998

  Fellowship Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology Women’s and Children’s Hospital LAC+USC Medical Center Los Angeles, California 1998-2001

  Licensures California #A054692 Expiration date: 4/30/11 DEA #BT4798584 Expiration date: 11/30/10

  Board Certifications The American Board of Obstetrics and Gynecology, Inc., Diplomate, 1/17/03

  The American Board of Obstetrics and Gynecology, Inc., Division of Reproductive Endocrinology and Infertility, Diplomate, 4/7/05

  3

  C. Professional Background:

  07/01/01 – Present Assistant Professor of Clinical Obstetrics and Gynecology Department of Obstetrics and Gynecology University of Southern California Keck School of Medicine Los Angeles, California

  Teaching Responsibilities:

   Lecturer: Physician Assistant Program, University of Southern California School of Medicine, Los Angeles, California, 1998 – 2001

   Lecturer: Year III/IV medical students

   Teach, medical students, interns and residents in Reproductive Endocrinology and Infertility Clinic

   Teach residents in Hysteroscopy Clinic

   Policy Group facilitator for Keck School of Medicine Year III course, “Discerning and Doing What’s Right: Ethical, Social & Legal Aspects of Modern Medicine,” May 13-20, 2003

  Administrative Responsibilities:

   Interview and rank applicants for residency in the Department of Obstetrics and Gynecology

   Interview and rank applicants for fellowship in Reproductive Endocrinology and Infertility

   Interview medical school applicants for the University of Southern California Keck School of Medicine

  Hospital Committees:

   Member, Quality Assurance Committee, Women’s and Children’s Hospital, LAC+USC Medical Center  Chairman for the Department of Obstetrics and Gynecology, Network Quality of Care Review Committee  Chairman for the Department of Obstetrics and Gynecology, Clinical Council  Chairman for the Department of Obstetrics and Gynecology, Peer Review Clinical Council

  4

  Ad Hoc Editorial Board:

   Clinical Cancer Research

   Contraception

   Journal of the American Medical Association (JAMA)

   Obstetrics and Gynecology

  Hospital Affiliations:

   Good Samaritan Hospital

   Huntington Memorial Hospital

   Los Angeles County+University of Southern California Medical Center

  Professional Organizations:

   American Society for Reproductive Medicine  Pacific Coast Reproductive Society  Society of Reproductive Endocrinology and Infertility  The American College of Obstetricians and Gynecologists, Fellow, 09/30/03

  Consultantship:

   Member, Professional Advisory Board of Resolve, Greater Los Angeles Chapter

  Honors and Awards:

  Undergraduate:

   California Scholarship Federation  Psi Chi Honor Society

  Medical School:

   McClelland Academic Scholarship  Wilmar Academic Scholarship

  5

  Fellowship:

   Wyeth-Ayerst Award (Most outstanding paper of the meeting) for abstract entitled: Vaginal administration of estradiol in preparation for oocyte donation. Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.

   Serono In-Training Award (First prize) for abstract entitled: Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.

   Ortho-McNeil Poster Award (First prize) for abstract entitled: Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 1-4, 2001, Los Angeles, California.

   Serono In-Training Award (First prize) for abstract entitled: Gonadotropin modulation of ovarian neoplastic cell proliferation in vitro. Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

   Fellow Award, co-author, for abstract entitled: Very high FSH levels do not result in additional follicular development in poor responders to ovarian stimulation. Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  6

  GRANTS

  1. Title: Is there evidence for preferential delivery of ovarian estradiol to the endometrium?

  Sponsor: Solvay Pharmaceuticals

  Period: December 1998 – June 2001

  Amount: $7,000.00

  2. Title: Evaluating the effects of raloxifene in the presence of medroxyprogesterone acetate on the OVCAR-3 cell line and its potential as a hormone replacement therapy in women with ovarian carcinoma

  Sponsor: Eli Lilly and Company

  Period: September 2002 – present

  Amount: $31,417.80

  3. Title: A pivotal, double-blind, comparative, multicenter study to determine the efficacy and safety of AdeptTM in the reduction of post-surgical adhesions after laparoscopic surgery

  Sponsor: ML Laboratories PLC

  Period: January 2002 – present

  Amount: $160,000.00

  4. Title: A phase II, prospective, randomized, assessor-blind, multicenter, dose finding, comparative study for the evaluation of the aromatase inhibitor anastrozole versus clomiphene citrate in stimulating follicular development and ovulation in infertile women with ovulatory dysfunction

  Sponsor: Serono, Inc.

  Period: May 2003 – present

  Amount: $84,613.00

  7

  LIST OF PUBLICATIONS

  Peer-Review Journals:

  1. Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D. Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 1994;86:1216-21.

  2. Tourgeman D, Gentzschein E, Stanczyk FZ, Paulson RJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol 1999;180:1480-3.

  3. Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril 2001;75:200-2.

  4. Tourgeman DE, Boostanfar R, Chang L, Lu J, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Fertil Steril 2001;75:1156-8.

  5. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis MM, Paulson RJ. The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system. J Assist Reprod Genet 2001;18:548-50.

  6. Tourgeman DE, Bhaumik M, Cooke GC, Najmabadi S, Paulson RJ, Jain JK. Pregnancy rates following fimbriectomy reversal via neosalpingostomy: A 10-year retrospective analysis. Fertil Steril 2001;76:1041-4.

  7. Tourgeman DE, Lu JJ, Boostanfar R, Amezcua C, Felix JC, Paulson RJ. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro. Fertil Steril 2002;78:1096-9.

  8. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC, Francis MM, Jain JK. Pregnancy in the sixth decade of life: Obstetrical outcomes in women of advanced reproductive age. JAMA 2002;288:2320-3.

  9. Boostanfar R, Amezcua CA, Tourgeman DE, Roy S, Felix JC, Stanczyk FZ. The growth effects of raloxifene, estradiol, medroxyprogesterone acetate, and progesterone on human endometrial adenocarcinoma cells. Fertil Steril 2003;79:223-5.

  10. Wang L, Felix JC, Lee JL, Tan PY, Tourgeman DE, O’Meara AT, Amezcua CA. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus. Gynecol Oncol 2003;90:402-6.

  11. Saadat P, Slater CC, Jain JK, Tourgeman DE, Stanczyk FZ, Paulson RJ. Treatmentassociated serum FSH levels in very poor responders to ovarian stimulation. J Assist Reprod Genet 2003;20:395-9.

  8

  12. Tourgeman DE. Ovulation induction is not the same as superovulation: The effect of selective estrogen receptor modulators and aromatase inhibitors. Fertil Steril 2003;80:1333-4.

  13. Saadat P, Boostanfar R, Slater CC, Tourgeman DE, Stanczyk FZ, Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of gonadotropin-releasing hormone agonists versus antagonists. Fertill Steril 2004;82:167-71.

  14. Mor E, Zograbyan A, Saadat P, Bayrak A, Tourgeman DE, Zhang C, Stanczyk FZ, Paulson RJ. The insulin resistant subphenotype of polycystic ovary syndrome: Clinical parameters and pathogenesis. Am J Obstet Gynecol 2004;190:1654-60.

  9

  Abstracts:

  1. Tourgeman D, Gentzschein E, Stanczyk FZ, Paulson RJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Presented at the 65th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16-29, 1998, Whistler, British Columbia, Canada.

  2. Tourgeman DE, Stanczyk FZ, Paulson RJ. Endocrine consequences of micronized estradiol administered vaginally or orally. Presented at the 46th Annual Meeting of the Society for Gynecologic Investigation, March 10-13, 1999, Atlanta, Georgia.

  3. Tourgeman DE, Coulam C, Stanczyk FZ, Paulson RJ. Vaginal administration of estradiol in preparation for oocyte donation. Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.

  4. Tourgeman DE, Coulam C, Stanczyk FZ, Paulson RJ. Vaginal administration of estradiol in preparation for oocyte donation. Presented at the 15th Annual Meeting of the European Society of Human Reproduction and Embryology, June 26-30, 1999, Tours, France.

  5. Tourgeman DE, Acacio BD, Sokol RZ, Guan C, Huang R, Roy S, Paulson RJ, Stanczyk FZ. Effect of DHEA supplementation on the pharmacokinetics of estrone sulfate in men and postmenopausal women. Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, March 22-25, 2000, Chicago, Illinois.

  6. Boostanfar R, Amezcua C, Tourgeman D, Roy S, Stanczyk FZ, Felix JC. The growth inhibitory effects of raloxifene on human endometrial adenocarcinoma Ishikawa cells. Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, March 22-25, 2000, Chicago, Illinois.

  7. Tourgeman DE, Chang L, Lu JJ, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.

  8. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ. Blastocyst transfer is associated with an increased rate of monozygotic twins. Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.

  9. Tourgeman DE, Jain JK, Bhaumik M, Cook GC, Najmabadi S, Paulson RJ. The success of neosalpingostomy following bilateral fimbriectomy: A 10-year retrospective analysis. Presented at the 56th Annual Meeting of the American Society for Reproductive Medicine, October 21-26, 2000, San Diego, California.

  10. Tourgeman D, Boostanfar R, Chang L, Lu JJ, Stanczyk FZ, Paulson RJ. Is there evidence for preferential delivery of ovarian estradiol to the endometrium? Presented at the 56th Obstetrical and Gynecological Assembly of Southern California Meeting, February 1-4, 2001, Los Angeles, California.

  10

  11. Boostanfar R, Tourgeman D, Amezcua C, Roy S, Stancyzk FZ, Felix JC. The growth effects of raloxifene, medroxyprogesterone acetate, and progesterone on human endometrial adenocarcinoma Ishikawa cells. Presented at the 56th Obstetrical and Gynecological Assembly of Southern California Meeting, February 1-4, 2001, Los Angeles, California.

  12. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ. High order multiple gestations as a result of monozygotic twinning associated with advanced embryo culture and blastocyst transfer. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14-17, 2001, Toronto, Ontario, Canada.

  13. Tourgeman DE, Lu JJ, Boostanfar R, Zheng W, Stanczyk FZ, Felix J, Paulson RJ. Gonadotropin modulation of ovarian neoplastic cell proliferation in vitro. Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.

  14. Tourgeman DE, Amezcua C, Boostanfar R, Stanczyk FZ, Felix C, Paulson RJ. Agonistic effects of raloxifene on the growth of ovarian adenocarcinoma (OVCAR-3) cells. Presented at the 17th Annual Meeting of the European Society of Human Reproduction and Embryology, July 1-4, 2001, Lausanne, Switzerland.

  15. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis M, Paulson RJ. The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system. Presented at the 17th Annual Meeting of the European Society of Human Reproduction and Embryology, July 1-4, 2001, Lausanne, Switzerland.

  16. Boostanfar R, Campeau JD, Saadat P, Tourgeman DE, Slater CC, Jain JK, diZerega GS, Kobak WH. Use of the Harmonic Scapel as a novel technique for distal neosalpingostomy. Presented at the 30th Annual Meeting of the American Association of Gynecologic Laparoscopists, November 16-19, 2001, San Francisco, California.

  17. Boostanfar R, Abbassi D, Tourgeman D, Saadat P, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of tamoxifen and clomiphene citrate in obese and non-obese anovulatory women: A prospective randomized trial. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.

  18. Boostanfar R, Slater C, Klumph S, Saadat P, Tourgeman D, Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of GnRH agonist vs. antagonist. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.

  19. Mor E, Boostanfar R, Saadat P, Tourgeman DE, Slater CC, Paulson RJ. Pregnancy outcome at the upper extreme of reproductive age: A comparison of two recipient groups. Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, October 12-17, 2002, Seattle, Washington.

  11

  20. Saadat P, Aliabadi T, Tourgeman DE, Mor E, Slater CC, Paulson RJ. The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tuboperitoneal disease. Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, October 12-17, 2002, Seattle, Washington.

  21. Abbassi D, Boostanfar R, Tourgeman D, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of tamoxifen and clomiphene citrate in obese and non-obese anovulatory women: A prospective randomized trial. Presented at the 69th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 22-27, 2002, Rancho Mirage, California.

  22. Saadat P, Aliabadi T, Jain JK, Tourgeman DE, Slater CC, Paulson RJ. The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tuboperitoneal disease. Presented at the 69th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 22-27, 2002, Rancho Mirage, California.

  23. Mor E, Saadat P, Bayrak A, Tourgeman DE, Jain JK, Francis MM, Paulson RJ. Pregnancy outcome in advanced reproductive age: A comparison between egg donation recipients and fertile women over 40 years of age. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, March 26-30, 2003, Washington, DC.

  24. Mor E, Saadat P, Bayrak A, Sokol RZ, Jain JK, Tourgeman DE, Paulson RJ. Insulin resistance in polycystic ovary ovarian syndrome: Impact on ovulation and common clinical and metabolic parameters. Presented at the 51st Annual Meeting of the Pacific Coast Reproductive Society, April 23-27, 2003, Rancho Mirage, California.

  25. Zograbyan A, Mor E, Zhang C, Saadat P, Bayrak A, Sokol RZ, Jain JK, Tourgeman DE, Stanczyk FZ, Paulson RJ. Insulin resistance in polycystic ovary syndrome: Clinical implications of fasting glucose and insulin levels. Presented at the 70th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16-21, 2003, Anchorage, Alaska. (Frank Lynch Memorial Essay Award).

  26. Mor E, Bayrak A, Tourgeman DE, Jain JK, Paulson RJ. Embryo implantation in women with Müllerian anomalies: Role of tubal embryo transfer. Presented at the 52nd Annual Meeting of the Pacific Coast Reproductive Society, April 28, 2004 – May 2, 2004, Rancho Mirage, California.

  12

  INVITED PRESENTATIONS

  Vaginal Administration of Hormonal Medication: Is This the Future? Presented at Grand Rounds, Department of Obstetrics and Gynecology, Keck School of Medicine of the University of Southern California, October 26, 2001, Los Angeles, California.

  Vaginal Administration of Hormonal Medication: Is This the Future? Presented at the USC OB/GYN Postgraduate Course, The Cutting Edge, November 1-4, 2001, University City, California.

  The Perimenopause and Menopause. Presented at Northridge Hospital Medical Center: Roscoe Campus, March 1, 2002, Northridge, California.

  The Menopause and Hormone WordStrment Therapy. Presented at Glendale Adventist Medical Center, March 6, 2002, Glendale, California.

  Vaginal Administration of Hormonal Medication: Is This the Future? Presented at the City of Hope, May 1, 2002, Duarte, California.

  Endometriosis. Presented at The Osler Institute Obstetrics and Gynecology Review Course, Radisson Hotel at Los Angeles International Airport, April 1-6, 2002, Los Angeles, California.

  Infertility. Presented at the Northridge Hospital Medical Center, January 30, 2003, Van Nuys, California.

  Prognosis for Age-Related Infertility: When is it Time to Panic? Presented at the Valley Presbyterian Hospital, February 18, 2003, Van Nuys, California.

  Prognosis for Age-Related Infertility. Presented at the 34th Annual Tucson Seminar in Obstetrics and Gynecology, February 24-26, 2003, Tucson, Arizona.

  Vaginal Hormone Administration: Is this the Future? Presented at the St. Joseph Hospital, March 4, 2003, Orange, California.

  Ectopic pregnancy. Presented at the The Osler Institute Obstetrics and Gynecology Review Course, Radisson Hotel at Los Angeles International Airport, April 7, 2003, Los Angeles, California.

  Endometriosis and adenomyosis. Presented at the The Osler Institute Obstetrics and Gynecology Review Course, Radisson Hotel at Los Angeles International Airport, April 7, 2003, Los Angeles, California.

  Infertility. Presented at the Caltech Women’s Center, November 20, 2003, Pasadena, California.

  Vaginal Hormone Administration: Is this the Future? Presented at the St. John’s Medical Center September 2005, Orange, California.

  Pre-Implantation Genetic Diagnosis: A Step Towards the Future. Presented at Kaiser Permanente March 2005 West Los Angeles, California.

  13

  Pre-Implantation Genetic Diagnosis: A Step Towards the Future. Presented at Kaiser Permanente June 2005 Bellflower, California.

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

关注0

粉丝0

帖子22

发布主题
一周热帖排行最近7x24小时热帖
欧路尔客服热线

15801391788

服务时间:工作日6:00-24:00
北京南四环西路128号诺德中心
邮箱:378691840@qq.com
  • 官方微信→

  • 在线咨询→

声明:本网站所有内容均出于传递更多信息之目的并,不意味着赞同其观点或证实其描述.本站不承担由此引起的法律责任.

北京欧路尔科技有限公司 ( 京ICP备2021003421号-5 ) www.oluer.com